Literature DB >> 13680393

Bacteremia with Mycoplasma hominis and Ureaplasma urealyticum in patients undergoing hysterectomy.

F Daxboeck1, E Iro, K Tamussino, R Krause, O Assadian, C Wenisch.   

Abstract

In the study presented here, the aim was to investigate the frequency and clinical significance of bacteremia with urogenital mycoplasmas in immunocompetent patients following gynecological surgery. Among 56 patients undergoing elective hysterectomy (mean age, 55 years; range, 32-82 years), Mycoplasma hominis and Ureaplasma urealyticum were detected in urine by PCR in 2 and 11 patients, respectively. Pre- and postoperative blood samples of the colonized patients were investigated for the colonizing species by PCR. In 4 of the 11 patients colonized by Ureaplasma urealyticum the pathogen was also detected from one of the postoperative blood samples, while no case of bacteremia with Mycoplasma hominis was detected. The postoperative course was uncomplicated in all patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680393     DOI: 10.1007/s10096-003-1001-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns.

Authors:  M Abele-Horn; C Wolff; P Dressel; A Zimmermann; W Vahlensieck; F Pfaff; G Ruckdeschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

2.  The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners.

Authors:  F E Keane; B J Thomas; C B Gilroy; A Renton; D Taylor-Robinson
Journal:  Int J STD AIDS       Date:  2000-06       Impact factor: 1.359

3.  Mycoplasmemia in adult male patients.

Authors:  M S Simberkoff; B Toharsky
Journal:  JAMA       Date:  1976-11-29       Impact factor: 56.272

4.  Prosthetic valve endocarditis caused by Mycoplasma hominis.

Authors:  M Blasco; L Torres; M L Marco; B Moles; M C Villuendas; J B García Moya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-08       Impact factor: 3.267

5.  Retroperitoneal abscess and bacteremia due to Mycoplasma hominis in a polytraumatized man.

Authors:  S Brunner; P Frey-Rindova; M Altwegg; R Zbinden
Journal:  Infection       Date:  2000 Jan-Feb       Impact factor: 3.553

6.  Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome.

Authors:  M Nasralla; J Haier; G L Nicolson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-12       Impact factor: 3.267

7.  Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001.

Authors:  Janet A Robertson; Gerald W Stemke; John W Davis; Ryĵ Harasawa; David Thirkell; Fanrong Kong; Maurice C Shepard; Denys K Ford
Journal:  Int J Syst Evol Microbiol       Date:  2002-03       Impact factor: 2.747

Review 8.  Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression.

Authors:  R D Meyer; W Clough
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

9.  Posthysterectomy wound infection. A review.

Authors:  C Miranda; J C Alados; J M Molina; C Dominguez; Y Partal; J A Miranda; M de la Rosa
Journal:  Diagn Microbiol Infect Dis       Date:  1993-07       Impact factor: 2.803

10.  Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years.

Authors:  P M Furr; D Taylor-Robinson; A D Webster
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

View more
  1 in total

Review 1.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.